1.
[Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma].
Staehler, M, Haseke, N, Schöppler, G, Stadler, T, Heinemann, G, Stief, CG
Der Urologe. Ausg. A. 2006;(10):1333-42; quiz 1343
Abstract
Sunitinib and Sorafenib are both effective angiogenetic inhibitors for the treatment of renal cell carcinoma. With these drugs of a new class of chronic therapy is performed. During chronic treatment, the inherent side effects may necessitate stopping the application of these drugs thus preventing the required effective therapy. Most of the effects can be avoided or attenuated by prophylaxis. In this paper the published data are reviewed and added with our experience in 138 patients over up to two and a half years.
2.
Antemortem diagnosis of gastrointestinal mucormycosis in neonates: report of two cases and review of literature.
Agarwal, K, Sharma, M, Singh, S, Jain, M
Indian journal of pathology & microbiology. 2006;(3):430-2
Abstract
Gastrointestinal mucormycosis has been reported more frequently in adults than in children. Due to high mortality diagnosis is usually made at autopsy. Only 3 cases of neonates surviving this disease have been described. We report two cases of preterm neonates presenting clinically with symptoms of necrotizing enterocolitis (NEC), but lacking radiological characteristics of NEC where histopathology confirmed the diagnosis of gastrointestinal mucormycosis involving caecum and appendix.
3.
Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review.
Hait, E, Liang, M, Degar, B, Glickman, J, Fox, VL
Pediatrics. 2006;(5):e1593-9
Abstract
Digestive tract involvement in Langerhans cell histiocytosis is exceedingly rare. We report a case of Langerhans cell histiocytosis in an otherwise thriving neonate presenting with hematochezia, anemia, and rash. We also review the few cases of Langerhans cell histiocytosis with gastrointestinal involvement reported in the English-language medical literature. Although gastrointestinal involvement can range in severity from mild to life-threatening, its presence may be indicative of multisystemic disease, and aggressive treatment should be considered.
4.
Consultation with the specialist: enteral nutrition.
Serrano, MS, Mannick, EE
Pediatrics in review. 2003;(12):417-23